Collectively, these data indicated that lapatinib and JQ1 cooperatively disrupt BRD4 and MED1 chromatin binding at a majority of genomic loci, consistent with their capacity to elicit potent effects on adaptive responses and suppress tumor cell growth12. Here, BRD4 is linked to neoplasm.